The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
Coordinated regulation of life and death by RB
Abstract
Recent studies have shown that RB can inhibit apoptosis, independently of its ability to block cell proliferation. This poses the question of how cells choose to grow or to die when RB becomes inactivated. RB is phosphorylated following mitogenic stimulation, but it is degraded in response to death stimuli. Most sporadic cancers also inactivate RB by phosphorylation, rather than losing RB entirely--possibly to exploit the survival advantage conferred by RB under stress. Drawing from the different mechanisms of RB inactivation, we propose two models for ways in which cells use RB to make the choice of life versus death.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Both these pathways are complex as they involve many upstream regulators and downstream effectors along with varying side branches (Chau and Wang, 2003; Levine and Oren, 2009).”
From Mechanisms of Cellular Senescence: Cell Cycle Arrest and Senescence Associated Secretory Phenotype (2021) · cites this paper as Chau and Wang, 2003
In the citing paper
“abnormal proliferation that is induced by loss of RB is often accompanied by increased cell death, through p53-dependent and independent mechanisms49,57,87–91.”
From Cellular mechanisms of tumour suppression by the retinoblastoma gene (2008) · cites this paper as [88]
Citations
Cites
CDK inhibitors: positive and negative regulators of G1-phase progression
Sherr, C. J., & Roberts, J. M. (1999) · Genes & Development · doi:10.1101/gad.13.12.1501 · Cited by 6,115
Sherr, C. J. (1996) · Science · doi:10.1126/science.274.5293.1672 · Cited by 5,379
Cellular survival: a play in three Akts
Datta, S. R., Brunet, A., & Greenberg, M. E. (1999) · Genes & Development · doi:10.1101/gad.13.22.2905 · Cited by 4,216
(2001) · PubMed · Cited by 2,381
Merlo, A., Herman, J. G., Mao, L., Lee, D. J., Gabrielson, E. W., Burger, P. C., Baylin, S. B., & Sidransky, D. (1995) · Nature Medicine · doi:10.1038/nm0795-686 · Cited by 1,992
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
Baylln, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., & Issa, J. J. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,919
Effects of an Rb mutation in the mouse
Jacks, T., Fazeli, A., Schmitt, E. M., Bronson, R. T., Goodell, M. A., & Weinberg, R. A. (1992) · Nature · doi:10.1038/359295a0 · Cited by 1,755
Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
Nobori, T., Miura, K., Wu, D. J., Lois, A., Takabayashi, K., & Carson, D. A. (1994) · Nature · doi:10.1038/368753a0 · Cited by 1,742
Mice deficient for Rb are nonviable and show defects in neurogenesis and haematopoiesis
Lee, E. Y.-H. P., Chang, C.-Y., Hu, N., Wang, Y.-C. J., Lai, C., Herrup, K., Lee, W., & Bradley, A. (1992) · Nature · doi:10.1038/359288a0 · Cited by 1,264
Control of apoptosis by Rel/NF-κB transcription factors
Barkett, M., & Gilmore, T. D. (1999) · Oncogene · doi:10.1038/sj.onc.1203238 · Cited by 1,202
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 291
The E2F-1 associated retinoblastoma-susceptibility gene product is modified by O-GlcNAc
Wells, L., Slawson, C. M., & Hart, G. W. (2010) · Amino Acids · doi:10.1007/s00726-010-0709-x · Cited by 54
Insights from mouse models into human retinoblastoma
MacPherson, D. P. (2008) · Cell Division · doi:10.1186/1747-1028-3-9 · Cited by 50
Comprehensive proteogenomic characterization of rare kidney tumors
Li, G. X., Chen, L., Hsiao, Y., Mannan, R., Zhang, Y., Luo, J., Petralia, F., Cho, H., Hosseini, N., Leprevost, F. D. V., et al. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101547 · Cited by 52
Hypermethylation of CpG island loci of multiple tumor suppressor genes in retinoblastoma
Cohen, Y., Merhavi-Shoham, E., Avraham, R. B., Frenkel, S., Pe’er, J., & Goldenberg‐Cohen, N. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2007.10.010 · Cited by 48
Delston, R. B., Matatall, K. A., Sun, Y., Onken, M. D., & Harbour, J. W. (2010) · Oncogene · doi:10.1038/onc.2010.442 · Cited by 49
Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN‐amplified retinoblastoma
Ewens, K. G., Bhatti, T. R., Moran, K. A., Richards‐Yutz, J., Shields, C. L., Eagle, R. C., & Ganguly, A. A. (2017) · Cancer Medicine · doi:10.1002/cam4.1010 · Cited by 46
Jiang, D., & Aguiar, R. C. T. (2013) · Blood · doi:10.1182/blood-2013-07-515254 · Cited by 45
MDM2-p53 Interaction in Paediatric Solid Tumours: Preclinical Rationale, Biomarkers and Resistance
Barone, G., Tweddle, D. A., Shohet, J. M., Chesler, L., Moreno, L., Pearson, A. D. J., & Maerken, T. V. (2014) · Current Drug Targets · doi:10.2174/13894501113149990194 · Cited by 45
Eloy, P., Dehainault, C., Sefta, M., Aerts, I., Doz, F., Cassoux, N., Rouïc, L. L.-L., Stoppa‐Lyonnet, D., Radvanyi, F., Millot, G. A., et al. (2016) · PLoS Genetics · doi:10.1371/journal.pgen.1005888 · Cited by 45
Lee, H. J., Lee, W. K., Kang, C. W., Ku, C. R., Cho, Y. H., & Lee, E. J. (2018) · Cancer Letters · doi:10.1016/j.canlet.2017.12.037 · Cited by 45
Nalam, R. L., Andreu‐Vieyra, C., Braun, R. E., Akiyama, H., & Matzuk, M. M. (2009) · Molecular Endocrinology · doi:10.1210/me.2009-0184 · Cited by 44
Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity
Copeland, R., Das, J. R., KANAAN, Y. M., Taylor, R. E., & Tizabi, Y. (2007) · Neurotoxicity Research · doi:10.1007/bf03033901 · Cited by 44
The retinoblastoma protein—from bench to bedside
Mittnacht, S. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2004.12.012 · Cited by 43
Sánchez-Martı́nez, C., Shih, C., Zhu, G., Li, T., Brooks, H. B., Patel, B. K. R., Schultz, R. M., DeHahn, T. B., Spencer, C. D., Watkins, S. A., et al. (2003) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(03)00792-3 · Cited by 43
Lai, A. Z., Cory, S. M., Zhao, H., Gigoux, M., Monast, A., Guiot, M.-C., Huang, S., Tofigh, A., Thompson, C., Naujokas, M. A., et al. (2014) · Science Signaling · doi:10.1126/scisignal.2004839 · Cited by 44
Coordination of Repair, Checkpoint, and Cell Death Responses to DNA Damage
Wang, J. Y. J., & Cho, S. K. (2004) · Advances in protein chemistry · doi:10.1016/s0065-3233(04)69004-8 · Cited by 43
Self-citationCaspase 6 Regulates B Cell Activation and Differentiation into Plasma Cells
Watanabe, C., Shu, G. L., Zheng, T. S., Flavell, R. A., & Clark, E. A. (2008) · The Journal of Immunology · doi:10.4049/jimmunol.181.10.6810 · Cited by 42
Simpson, D. S., Mason-Richie, N. A., Gettler, C. A., & Wikenheiser‐Brokamp, K. A. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1359 · Cited by 41
Phosphorylated Retinoblastoma Protein Complexes with pp32 and Inhibits pp32-mediated Apoptosis
Adegbola, O., & Pasternack, G. R. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411382200 · Cited by 42
Role of the retinoblastoma tumor suppressor protein in cellular differentiation
Nguyen, D. X., & McCance, D. J. (2005) · Journal of Cellular Biochemistry · doi:10.1002/jcb.20375 · Cited by 40
Direct Binding of Apoptosis Signal-regulating Kinase 1 to Retinoblastoma Protein
Dasgupta, P., Betts, V., Rastogi, S., Joshi, B., Morris, M. D., Brennan, B. M., Ordonez‐Ercan, D., & Chellappan, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312273200 · Cited by 39
Arnold, N. B., & Korc, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m500583200 · Cited by 39
Nucleo-cytoplasmic communication in apoptotic response to genotoxic and inflammatory stress
Wang, J. Y. J. (2005) · Cell Research · doi:10.1038/sj.cr.7290263 · Cited by 37
Self-citationRegulation of Vascular Smooth Muscle Proliferation by Heparin
Fasciano, S., Patel, R. C., Handy, I., & Patel, C. V. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m411458200 · Cited by 37
Zhang, P., Pei, C., Wang, X., Xiang, J., Sun, B.-F., Cheng, Y., Qi, X., Marchetti, M., Xu, J.-W., Sun, Y.-P., et al. (2017) · Developmental Cell · doi:10.1016/j.devcel.2017.10.033 · Cited by 36
Vasavada, R. C., Cózar‐Castellano, I., Sipula, D., & Stewart, A. F. (2006) · Diabetes · doi:10.2337/db06-0517 · Cited by 35
Stoeckius, M., Erat, A., Fujikawa, T., Hiromura, M., Koulova, A., Otterbein, L. E., Bianchi, C. F., Tobiasch, E., Dagon, Y., Sellke, F. W., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.266510 · Cited by 32
The RB Protein Family in Retinal Development and Retinoblastoma: New Insights from New Mouse Models
Bremner, R., Chen, D., Pacal, M., Livne‐Bar, I., & Agochiya, M. (2004) · Developmental Neuroscience · doi:10.1159/000082284 · Cited by 32
Ignatoski, K. M. W., Dziubinski, M. L., Ammerman, C., & Ethier, S. P. (2005) · Neoplasia · doi:10.1593/neo.05106 · Cited by 32
Tumor promotion by caspase-resistant retinoblastoma protein
Borges, H. L., Bird, J., Wasson, K., Cardiff, R. D., Varki, N. M., Eckmann, L., & Wang, J. Y. J. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503925102 · Cited by 31
Self-citationLi, B., Zhang, G. C., Wang, Z., Yang, Y., Wang, C., Fang, D., Liu, K., Wang, F., & Mei, Y. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04330-2 · Cited by 29
Sun, L., Quan, H., Xie, C., Wang, L., Hu, Y., & Lou, L. (2014) · PLoS ONE · doi:10.1371/journal.pone.0090627 · Cited by 29
How the other half lives, the amino‐terminal domain of the retinoblastoma tumor suppressor protein
Goodrich, D. W. (2003) · Journal of Cellular Physiology · doi:10.1002/jcp.10358 · Cited by 30
Association Between Genotype and Phenotype in Consecutive Unrelated Individuals With Retinoblastoma
Salviat, F., Gauthier‐Villars, M., Carton, M., Cassoux, N., Rouïc, L. L.-L., Dehainault, C., Lévy, C., Golmard, L., Aerts, I., Doz, F., et al. (2020) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2020.2100 · Cited by 28
Sato, A., Asano, T., Ito, K., Sumitomo, M., & Asano, T. (2011) · British Journal of Urology · doi:10.1111/j.1464-410x.2011.10533.x · Cited by 28
Evidence for serpinB2-independent protection from TNF-α-induced apoptosis
Fish, R. J., & Kruithof, E. (2005) · Experimental Cell Research · doi:10.1016/j.yexcr.2005.11.003 · Cited by 28
Retinoblastoma Protein Is Frequently Absent or Phosphorylated in Anaplastic Large-Cell Lymphoma
Rassidakis, G. Z., Lai, R. L., Herling, M., Cromwell, C. C., Schmitt-Graeff, A. H., & Medeiros, L. J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63782-0 · Cited by 28
Significance of RB Loss in Unlocking Phenotypic Plasticity in Advanced Cancers
Venkadakrishnan, V. B., Yamada, Y., Weng, K., Idahor, O., & Beltran, H. (2023) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-23-0045 · Cited by 28
Lentine, B., Antonucci, L., Hunce, R., Edwards, J., Marallano, V. J., & Krucher, N. A. (2012) · Cell Cycle · doi:10.4161/cc.21693 · Cited by 26
Aberrant E2F activation by polyglutamine expansion of androgen receptor in SBMA neurotoxicity
Suzuki, E., Zhao, Y., Ito, S., Sawatsubashi, S., Murata, T., Furutani, T., Shirode, Y., Yamagata, K., Tanabe, M., Kimura, S., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0809819106 · Cited by 27
Differential regulation of apoptotic genes by Rb in human versus mouse cells
Young, A. P., & Longmore, G. D. (2004) · Oncogene · doi:10.1038/sj.onc.1207330 · Cited by 27
Araki, K., Kawauchi, K., Sugimoto, W., Tsuda, D., Oda, H., Yoshida, R., & Ohtani, K. (2018) · Communications Biology · doi:10.1038/s42003-018-0246-9 · Cited by 28
Chu, S. H., McDonald, T., & Bhatia, R. (2010) · Leukemia · doi:10.1038/leu.2010.24 · Cited by 24
Blockade of Tumor Necrosis Factor-induced Bid Cleavage by Caspase-resistant Rb
Huang, X., Masselli, A., Frisch, S. M., Hunton, I. C., Jiang, Y., & Wang, J. Y. J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702261200 · Cited by 24
Self-citationTumour-suppressor function in the nervous system
Baker, S. J., & McKinnon, P. J. (2004) · Nature reviews. Cancer · doi:10.1038/nrc1297 · Cited by 24
Xia, S., Chang-xi, Z., Kalionis, B., Shuang, X., Ge, H., & Gao, W. (2020) · Aging and Disease · doi:10.14336/ad.2019.0508 · Cited by 23
Valatkaitė, E., Baušytė, R., Vitkevičienė, A., Ramašauskaitė, D., & Navakauskienė, R. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.765265 · Cited by 23
Iscador Qu inhibits doxorubicin-induced senescence of MCF7 cells
Srdić‐Rajić, T., Santibanez, J. F., Kanjer, K., Miletić, N. T., Cavic, M. R., Galun, D., Jevric, M., Kardum, N., Konić‐Ristić, A., & Zoranovic, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-03898-0 · Cited by 23
Wu, X., Shi, J., Wu, Y., Yi, T., Hou, J., Meng, X., Hu, X., Han, Y., Jiang, W., Tang, S., et al. (2010) · Cancer Biology & Therapy · doi:10.4161/cbt.10.11.13669 · Cited by 22
Macías, M., Dean, M. C., Atkinson, A., Jiménez‐Morales, S., García-Vázquez, F. J., Saldaña‐Alvarez, Y., Ramírez‐Bello, J., Chávez, M. E. Q., & Orozco, L. (2008) · Cancer Biomarkers · doi:10.3233/cbm-2008-4205 · Cited by 22
Oshikawa, M., Okada, K., Nakajima, K., & Ajioka, I. (2013) · Development · doi:10.1242/dev.095653 · Cited by 22
Novel retinoblastoma binding protein RBBP9 modulates sex-specific radiation responses in vivo
Cassie, S., Koturbash, I., Hudson, D., Baker, M., Ilnytskyy, Y., Rodriguez‐Juarez, R., Weber, E., & Kovalchuk, O. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi261 · Cited by 22
Al‐Khalaf, H. H., Lach, B., Allam, A. A. K., Hassounah, M. I., Alkhani, A. M., Elkum, N. B., Alrokayan, S., & Aboussekhra, A. (2007) · Brain Research · doi:10.1016/j.brainres.2007.10.074 · Cited by 22
Chau, B. N., Pan, C. W., & Wang, J. Y. J. (2006) · PLoS ONE · doi:10.1371/journal.pone.0000082 · Cited by 22
Self-citationXu, X., Wang, J.-T., Li, M., & Liu, Y. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.719963 · Cited by 21
Self-citationThe Role of RB in Prostate Cancer Progression
Burkhart, D. L., Morel, K. L., Sheahan, A. V., Richards, Z. A., & Ellis, L. (2019) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-32656-2_13 · Cited by 24
Transglutaminases in Neurodegenerative Disorders
Bailey, C. D. C., Tucholski, J., & Johnson, G. V. W. (2005) · KARGER eBooks · doi:10.1159/000084238 · Cited by 21
Motsch, I., Kaluarachchi, M. R., Emerson, L. J., Brown, C. A., Brown, S., Dabauvalle, M., & Ellis, J. A. (2005) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2005.04.004 · Cited by 21
Dissecting Pin1 and phospho‐pRb regulation
Rizzolio, F., Caligiuri, I., Lucchetti, C., Fratamico, R., Tomei, V., Gallo, G., Agelan, A., Ferrari, G. M., Toffoli, G., Klein–Szanto, A. J., et al. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.24107 · Cited by 21
Gastrointestinal cancer - only a deregulation of stem cell differentiation? (Review)
Neureiter, D., Herold, C., & Ocker, M. (2006) · International Journal of Molecular Medicine · doi:10.3892/ijmm.17.3.483 · Cited by 20
Liu, H., Knabb, J. R., Spike, B. T., & Macleod, K. F. (2009) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-08-0439 · Cited by 20
Tula-Sanchez, A. A., Havas, A. P., Alonge, P. J., Klein, M. E., Doctor, S. R., Pinkston, W., Glinsmann‐Gibson, B., Rimsza, L. M., & Smith, C. L. (2013) · Cancer Biology & Therapy · doi:10.4161/cbt.25941 · Cited by 21
A stepwise strategy for rapid and cost-effective RB1 screening in Indian retinoblastoma patients
Thirumalairaj, K., Abraham, A., Devarajan, B., Gaikwad, N., Kim, U. R., Muthukkaruppan, V., & Vanniarajan, A. (2015) · Journal of Human Genetics · doi:10.1038/jhg.2015.62 · Cited by 20
Protein phosphatase 1α activity prevents oncogenic transformation
Liu, C. W. Y., Wang, R., & Berndt, N. (2006) · Molecular Carcinogenesis · doi:10.1002/mc.20191 · Cited by 20
Kuns, R., Kissil, J. L., Newsham, I., Jacks, T., Gutmann, D. H., & Sherman, L. S. (2005) · Oncogene · doi:10.1038/sj.onc.1208813 · Cited by 20
Saleh‐E‐In, M. M., & Choi, Y. E. (2021) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2021.113967 · Cited by 19
The Crystal Structure of CCG1/TAFII250-interacting Factor B (CIB)
Padmanabhan, B., Kuzuhara, T., Adachi, N., & Horikoshi, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m312165200 · Cited by 19
Carboni, N., Porcu, M., Mura, M., Cocco, E. E., Marrosu, G., Maioli, M. A., Solla, E., Tranquilli, S., Orrù, P., & Marrosu, M. G. (2009) · Muscle & Nerve · doi:10.1002/mus.21443 · Cited by 18
Bonvini, P., Zorzi, E., Mussolin, L., Monaco, G., Pigazzi, M., Basso, G., & Rosolen, A. (2009) · Haematologica · doi:10.3324/haematol.2008.004861 · Cited by 18
Fan, Z., Zhang, H., & Zhang, Q. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401825 · Cited by 18
Edgar, K. A., Belvin, M. P., Parks, A. L., Whittaker, K. L., Mahoney, M. B., Nicoll, M., Park, C. C., Winter, C. G., Chen, F., Lickteig, K., et al. (2005) · Genetics · doi:10.1534/genetics.104.036343 · Cited by 18
mTOR and SGLT-2 Inhibitors: Their Synergistic Effect on Age-Related Processes
Troise, D. E., Mercuri, S., Infante, B., Losappio, V., Cirolla, L. A., Netti, G. S., Ranieri, E., & Stallone, G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25168676 · Cited by 17
Agoston, A. T., Argani, P., Marzo, A. M. D., Hicks, J. L., & Nelson, W. G. (2007) · American Journal Of Pathology · doi:10.2353/ajpath.2007.060779 · Cited by 16
Cytoplasmic translocation of the retinoblastoma protein disrupts sarcomeric organization
Araki, K., Kawauchi, K., Hirata, H., Yamamoto, M., & Taya, Y. (2013) · eLife · doi:10.7554/elife.01228 · Cited by 16
Retinoblastoma tumor suppressor protein in pancreatic progenitors controls α- and β-cell fate
Cai, E. P., Wu, X., Schroer, S. A., Elia, A., Nostro, M. C., Zacksenhaus, E., & Woo, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1303386110 · Cited by 16
Molecular targets of selenium in prostate cancer prevention (Review)
Abdulah, R. (2011) · International Journal of Oncology · doi:10.3892/ijo.2011.1035 · Cited by 15
Retinoblastoma 1 protects T cell maturation from premature apoptosis by inhibiting E2F1
Zhang, Z., Liu, W., Zhao, L., Huang, Z., Chen, X., Ma, N., Xu, J., Zhang, W., & Zhang, Y. (2018) · Development · doi:10.1242/dev.158139 · Cited by 15
Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
Indovina, P., Pentimalli, F., Conti, D., & Giordano, A. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.06.003 · Cited by 15
Masselli, A., & Wang, J. Y. J. (2005) · Oncogene · doi:10.1038/sj.onc.1209161 · Cited by 15
Self-citationWagner, S., & Roemer, K. (2005) · Biochemical Pharmacology · doi:10.1016/j.bcp.2004.12.017 · Cited by 15
Reduction of apoptosis in Rb-deficient embryos via Abl knockout
Borges, H. L., Hunton, I. C., & Wang, J. Y. J. (2007) · Oncogene · doi:10.1038/sj.onc.1210157 · Cited by 14
Self-citationAaltonen, V., Koivunen, J. P., Laato, M. K., & Peltonen, J. T. K. (2007) · Cancer Letters · doi:10.1016/j.canlet.2007.01.011 · Cited by 16
Cancer modelling in the NGS era – Part I: Emerging technology and initial modelling
Rovigatti, U. (2015) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2015.05.017 · Cited by 13
Simultaneous expression of MMB-FOXM1 complex components enables efficient bypass of senescence
Kumari, R., Hummerich, H., Shen, X., Fischer, M., Litovchick, L., Mittnacht, S., DeCaprio, J. A., & Jat, P. (2021) · Scientific Reports · doi:10.1038/s41598-021-01012-z · Cited by 13
Involvement of Bcl-XL deamidation in E1A-mediated cisplatin sensitization of ovarian cancer cells
Chang, C.-Y., Lin, Y.-M., Lee, W.-P., Hsu, H.-H., & Chen, E. I.-T. (2005) · Oncogene · doi:10.1038/sj.onc.1209294 · Cited by 13
Lv, X., Wang, N., Su, L., Zhang, S., & Miao, J. (2006) · Developmental Neuroscience · doi:10.1159/000095112 · Cited by 13
Integrated Stability and Activity Control of the Drosophila Rbf1 Retinoblastoma Protein
Zhang, L., Wei, Y., Pushel, I., Heinze, K., Elenbaas, J. S., Henry, R. W., & Arnosti, D. N. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.586818 · Cited by 12
Gekonge, B., Raymond, A., Yin, X., Kostman, J. R., Mounzer, K., Collman, R. G., Showe, L. C., & Montaner, L. J. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.1111552 · Cited by 12
Wang, G., Ren, Z., Wang, P., Su, C., Zhang, W., LIU, Z.-G., Zhang, L., Zhao, X., & Chen, G. (2014) · Oncology Reports · doi:10.3892/or.2014.3233 · Cited by 11
The Apoptotic Paradox in Retinoblastoma
Sitorus, R. S., Gumay, S., & van der Valk, P. (2009) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2009.04719.x · Cited by 11
Epithelial-Specific Deletion of 11β-HSD2 Hinders Apcmin/+ Mouse Tumorigenesis
Jiang, L., Yang, S., Yin, H., Fan, X., Wang, S., Yao, B., Pozzi, A., Chen, X., Harris, R. C., & Zhang, M. (2013) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-13-0084-t · Cited by 11
Generation of a Retinoblastoma (Rb)1-inducible dominant-negative (DN) mouse model
Tarang, S., Doi, S. M. D. S. R., Gurumurthy, C. B., Harms, D. W., Quadros, R. M., & Rocha-Sanchez, S. M. (2015) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2015.00052 · Cited by 12
Functional and physical communication between oncoproteins and tumor suppressors
Prochownik, E. V. (2005) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-005-5199-8 · Cited by 10
Inhibition of pRB Pathway Differentially Modulates Apoptosis in Esophageal Cancer Cells
Soletti, R. C., Biasoli, D., Rodrigues, N. A. L. V., Delou, J. M. D. A., Maciel, R. D. M., Chagas, V. L. A., Martins, R. A. P., Rehen, S. K., & Borges, H. L. (2017) · Translational Oncology · doi:10.1016/j.tranon.2017.06.008 · Cited by 9
Liu, S., Zhang, W., Liu, K., WANG, Y., Ji, B., & Liu, Y. (2014) · Oncology Reports · doi:10.3892/or.2014.3503 · Cited by 9
RetractedGuo, X., Hutcheon, A. E. K., & Zieske, J. D. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.03-1164 · Cited by 9
Berns, A. J. M. (2003) · Nature · doi:10.1038/424140a · Cited by 9
Morgans, A. K., Dale, W., & Briganti, A. (2017) · American Society of Clinical Oncology Educational Book · doi:10.1200/edbk_175491 · Cited by 9
Pui, C. (2006) · Cambridge University Press eBooks · doi:10.1017/cbo9780511471001.017 · Cited by 9
Cao, J., Arulanandam, R., Vultur, A., Anagnostopoulou, A., & Raptis, L. H. (2007) · Molecular Carcinogenesis · doi:10.1002/mc.20278 · Cited by 9
Metadata
- Authors
- Chau, B. N., & Wang, J. Y. J.
- Affiliations
- University of California San Diego (US)
- Corresponding author
- Wang, Jean Y.J.
- ORCID
- Wang, Jean Y.J.
- Venue
- Nature Reviews Cancer
- Published
- 2003-02
- Volume
- 3
- Issue
- 2
- Pages
- 130-138
- ISSN
- 1474-175X (ISSN-L)
- 1474-1768
- OpenAlex
- W1979104079
- Cited by
- 292
- References
- 64
- Citations by year
- 2025: 2 · 2024: 5 · 2023: 9 · 2022: 6 · 2021: 8 · 2020: 6 · 2019: 3 · 2018: 8 · 2017: 6 · 2016: 5 · 2015: 10 · 2014: 10 · 2013: 11 · 2012: 12
- FWCI
- 3.40
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature reviews. Cancer (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Damon Runyon Cancer Research Foundation
- National Cancer Institute (R01CA058320)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Cell death mechanisms and regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › PI3K/AKT/mTOR signaling in cancer
- Keywords
- retinoblastoma protein, apoptosis, cell proliferation, retinoblastoma protein phosphorylation, mitogen stimulation, cancer survival, cell fate determination, Rb inactivation
- MeSH terms
- Animals, Cell Cycle, Cell Survival, Humans, Neoplasms, Retinoblastoma Protein, Apoptosis, Mice, Knockout, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review